Clinical trials
Surveillance clinical trials
Below are recruiting surveillance clinical trials, each written for real people, not researchers. We’re tracking 310 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06073769Recruiting
Safety study of oral azacitidine for AML in Korea
This study is monitoring the safety of the drug oral azacitidine (also called Onureg) when given as maintenance therapy to adults with acute myeloid leukemia (AML). It is designed to track how well patients tolerate the medicine in real-world use in Korea.
SeoulAges 19 years+ - NCT06073860Recruiting
Safety study of Luspatercept for MDS or thalassemia in Korea
This study is checking the safety of a drug called Luspatercept (brand name Reblozyl) for people in Korea who have myelodysplastic syndrome (a blood disorder) or beta-thalassemia (a type of inherited anemia). It is designed to monitor how safe the drug is when used as prescribed by your doctor.
SeoulAges 19 years+ - NCT06073847Recruiting
Safety study of fedratinib in Korean patients with myelofibrosis
This study looks at the safety of the drug fedratinib in Korean patients with myelofibrosis. It will help doctors better understand how well patients tolerate the drug when it's used as approved.
SeoulAges 19 years+ - NCT07658716Recruiting
Colonoscopy surveillance recommendation study
This study tests a tool to help doctors make better recommendations for colonoscopy follow-up. It may improve how often patients get the right screening.
New York, New YorkAges 18 years+ - NCT07621653Recruiting
Safety check-in after meningococcal vaccine in Korea
This study watches for any side effects or health changes after you receive the MenQuadfi vaccine, which protects against four types of meningococcal bacteria. Your doctor will follow up with you to make sure the vaccine is safe and working well.
BusanAges 1 month–55 years - NCT06683157Recruiting
Study of calf vein clots with ultrasound monitoring
This study follows people with a blood clot in the calf vein to learn how the clot changes over time using repeat ultrasound scans. It may help doctors understand who needs treatment and who can be watched safely.
Dresden, SaxonyAges 18 years+ - NCT07616258Recruiting
Reducing follow-up visits after breast cancer treatment
This study tests whether some patients who finished curative breast cancer treatment can safely have fewer follow-up appointments and scans. Researchers want to see if less frequent monitoring is safe for patients without any signs of cancer returning.
Beaumont, DublinAges 18 years+ - NCT07609277Recruiting
Blood test to track giant cell bone tumors
This study uses a simple blood test (TRACP-5b) to help diagnose and monitor giant cell tumors of the bone. Researchers want to see if this test can better track how the tumor responds to treatment or comes back over time.
BrnoAges 18 years+ - NCT07599449Recruiting
Tracking respiratory infections in French primary care
This study tracks viruses that cause sudden colds and flu-like illnesses during winter months in France. Researchers collect information from patients seen by participating doctors to better understand which respiratory viruses are circulating and help prepare for future outbreaks.
ParisAges Any age - NCT07570394Recruiting
Breztri safety study for COPD and asthma patients in Korea
This study collects information on how Breztri (a medicine for COPD and asthma) works in real-life patients who have just started taking it. It helps ensure the medicine is safe and effective for people like you.
ChuncheonAges Any age - NCT07574151Recruiting
Clarity of study info for aortic disease
This study is testing how clear and acceptable the information materials are for people with thoracic aortic disease. It does not test any new treatments but aims to improve how studies are explained to patients.
NottinghamAges 18 years+ - NCT07571993Recruiting
Tracking Rheumatoid Arthritis Remission and Treatment Changes
This study follows people with rheumatoid arthritis (RA) who have achieved remission—meaning their disease is well-controlled—to see how safely doctors can reduce or stop their medications over time. You would be monitored regularly to ensure your RA stays in remission.
Pavia, PaviaAges 18 years+ - NCT07562529Enrolling by invitation
Pneumococcal Bacteria Study in Hospitalized Vietnamese Children
This research study examines how a common bacterium called pneumococcus lives in the noses of young children who are hospitalized with respiratory symptoms. The goal is to understand which types of pneumococcus are present in Vietnam to help improve prevention and treatment strategies.
HanoiAges 2 months–5 years - NCT07558889Recruiting
Understanding endometrial cancer patterns in Italy
This study collects information from patients diagnosed with endometrial cancer (a cancer of the uterus lining) to understand patterns of the disease and how it behaves. Researchers will review your medical records and cancer tissue samples to learn more about treatment outcomes.
RomaAges 18 years+ - NCT07556913Recruiting
Safety study of elafibranor medicine during pregnancy
This study tracks the safety of a medicine called elafibranor when taken before or during pregnancy. Researchers want to understand how the medicine affects pregnant people and their babies to help keep both safe.
Wilmington, North CarolinaAges Any age - NCT07547163Recruiting
Patient feedback on low-grade brain tumor treatment
This study asks patients with a specific type of low-grade brain tumor (IDH mutant grade 2 glioma) to share their experiences and quality of life while receiving a treatment called vorasidenib, with or without radiation. Your feedback helps doctors understand how well the treatment works from your perspective.
MilanAges 18 years+ - NCT07542171Recruiting
Outcomes after incomplete early colon cancer removal
This study follows patients who had early colon cancer removed by endoscopy (a camera procedure) but the removal was incomplete. Researchers will track what happens when patients either have surgery afterward or are closely watched instead, to understand the best next steps.
Guangzhou, GuangdongAges 18–75 - NCT06653127Recruiting
Using a blood test to watch for biliary tract cancer return
This trial studies a new blood test that looks for bits of tumor DNA (ct-mtDNA) to see if it can detect if biliary tract cancer has come back earlier than standard scans. The test might help doctors monitor for recurrence more closely.
Wuhan, HubeiAges 18 years+ - NCT06653062Recruiting
Blood test to watch for liver cancer return
This trial studies a new blood test that looks for DNA from cancer cells' mitochondria to see if it can catch liver cancer coming back earlier. The goal is to help doctors find recurrence faster and improve follow-up care.
Wuhan, HubeiAges 18 years+ - NCT07531784Recruiting
Blood Test to Detect Heart Rejection After Transplant
This Swedish study tests whether a simple blood test can detect early signs that your body is rejecting a transplanted heart. The test looks for DNA fragments in your blood that may signal rejection before symptoms appear, potentially helping doctors catch problems sooner.
StockholmAges 18 years+ - NCT07514143Recruiting
Bladder Cancer Detection Study Using Urine Test
This study tests a new urine-based test called EpiCheck to help detect bladder cancer. You'll provide urine samples before or during a bladder procedure you're already scheduled to have, and researchers will see how well the test works.
San Diego, CaliforniaAges 22 years+ - NCT04985487Recruiting
Safety follow-up for brolucizumab in neovascular AMD
This study tracks the real-world safety of brolucizumab in adults with neovascular age-related macular degeneration (nAMD). If you’re already prescribed this medicine, the study may help confirm it continues to be safe and well-tolerated over time.
Daegu, Dalseo GuAges 18–100 - NCT05515367RecruitingPhase 4
Real-world safety study of desidustat for kidney anemia
This study tracks the real-world safety of desidustat in adults with anemia caused by chronic kidney disease (CKD). It’s meant to see whether the medicine is safe when used in everyday care, not just in tightly controlled settings.
Sheikhpura, BiharAges 18–85 - NCT06306755Recruiting
Risk-based screening for esophageal and gastric cancer
This study tests a new way of screening for esophagus and stomach cancer by using a risk-based approach. It aims to see if this works better than standard screening, and is offered to people in certain villages in China.
Beijing, Beijing MunicipalityAges 50–69
Hear when a new Surveillance trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for surveillance?
- Yes. Clin2 currently lists 310 recruiting surveillance studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a surveillance trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a surveillance trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.